Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Cellyan Biotechnology Co., Ltd

HKPD•NASDAQ
Healthcare
Medical - Pharmaceuticals
$0.69
$-0.00(-0.44%)
U.S. Market is Open • 14:22

Cellyan Biotechnology Co., Ltd (HKPD) Stock Overview

Explore Cellyan Biotechnology Co., Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.5M
P/E Ratio-252.53
EPS (TTM)$0.17
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$0.61
3 Months$0.55
1 Year Target$0.36

HKPD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellyan Biotechnology Co., Ltd (HKPD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -252.53 and a market capitalization of 7.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.54%
5-Day Change
-16.87%
1-Month Change
-14.86%
3-Month Change
-33.33%
6-Month Change
-32.67%
Year-to-Date (YTD) Change
-15.72%
1-Year Change
-61.58%
3-Year Change
-75.89%
5-Year Change
-75.89%
All-Time (Max) Change
-75.89%

Contact Information

http://www.9zt.hk
852 2618-9289
Well Town Industrial Building, Yau Tong, NaN, 999077

Company Facts

270 Employees
IPO DateJan 15, 2025
CountryHK
Actively Trading

Frequently Asked Questions